Company raises 2025 revenue guidance to a range of $122 million to $126 millionSAN JOSE, Calif., Aug. 06, 2025 (GLOBE ...

Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...

The tech trade is proving resilient, even unstoppable, while the firms that gained by helping people lose weight are ...

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...

A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...

A new weight loss plan that embraces real food, flexibility and freedom is climbing Amazon’s bestseller charts - overtaking ...

The Britalian Diet, created by Derbyshire based author and nutrition coach Francesca Bell, is resonating with readers who are ...

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program could run into problems with voluntary participation and concerns about ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

Novo Nordisk's technical chart is displaying a largely bearish trend amid a profit warning tied to its blockbuster obesity ...

Hers reports 12% of Americans feel judged by doctors for their weight, highlighting significant weight bias in healthcare and ...

People on weight-loss drugs often lose muscle mass while they lose weight, but new scientific findings suggest boosting your ...